Evidence map›Paper›PMID 26377489›Full record

ReviewInternational urology and nephrology2015

Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients.

Charles Chazot, Ken Farrington, Ionut Nistor, Wim Van Biesen, Hanneke Joosten, Daniel Teta, Dimitrie Siriopol, Adrian Covic

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urology and nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Charles ChazotNephroCare Tassin-Charcot, Sainte Foy Les Lyon, France.
Ken FarringtonRenal Unit, Lister Hospital, Stevenage, Hertfordshire, UK.
Ionut NistorERBP, Ghent University Hospital, Ghent, Belgium.
Wim Van BiesenERBP, Ghent University Hospital, Ghent, Belgium.
Hanneke JoostenDepartment of Internal Medicine, UMCG, Groningen, The Netherlands.
Daniel TetaService of Nephrology, Department of Medicine, University Hospital Lausanne, Lausanne, Switzerland.
Dimitrie SiriopolNephrology Department, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Adrian CovicNephrology Department, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania. accovic@gmail.com.
Grigore T. Popa University of Medicine and Pharmacy · RODialyse Centrum Groningen · NLGhent University Hospital · BELister Hospital · GBNephroCare Tassin-Charcot · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, an increasing number of patients over 75 years of age are starting renal replacement therapy. Frailty is highly prevalent in elderly patients with end-stage renal disease (ESRD) in the context of the increased prevalence of some ESRD-associated conditions: protein-energy wasting, inflammation, anaemia, acidosis or hormonal disturbances. There are currently no hard data to support guidance on the optimal duration of dialysis for frail/elderly ESRD patients. The current debate is not about starting dialysis or managing conservatory frail ESRD patients, but whether a more intensive regimen once dialysis is initiated (for whatever reasons and circumstances) would improve patients' outcome. The most important issue is that all studies performed with extended/alternative dialysis regimens do not specifically address this particular type of patients and therefore all the inferences are derived from the general ESRD population. Care planning should be responsive to end-of-life needs whatever the treatment modality. Care in this setting should focus on symptom control and quality of life rather than life extension. We conclude that, similar to the general dialysed population, extensive application of more intensive dialysis schedules is not based on solid evidence. However, after a thorough clinical evaluation, a limited period of a trial of intensive dialysis could be prescribed in more problematic patients.

Indexed as

Frail ElderlyPatient Care PlanningAgedHumansKidney Failure, ChronicRenal DialysisTime FactorsDialysisElderlyFrail

Identifiers

PMID26377489
OpenAlexW1742624426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.